Related references
Note: Only part of the references are listed.An elevated FIB-4 score predicts liver cancer development: A longitudinal analysis from 29,999 patients with NAFLD
Sven H. Loosen et al.
JOURNAL OF HEPATOLOGY (2022)
Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu
Samarth Patel et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis
Mario Masarone et al.
METABOLOMICS (2021)
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
Ramy Younes et al.
JOURNAL OF HEPATOLOGY (2021)
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
Annalisa Berzigotti et al.
JOURNAL OF HEPATOLOGY (2021)
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Mojgan Masoodi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD
Stergios A. Polyzos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent
Guillaume Grzych et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
cis-4-[18F]fluoro-L-proline Molecular Imaging Experimental Liver Fibrosis
Qi Cao et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Application of transient elastography in nonalcoholic fatty liver disease
Xinrong Zhang et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
Melania Gaggini et al.
HEPATOLOGY (2018)
Metabolomic-Based Noninvasive Serum Test to Diagnose Nonalcoholic Steatohepatitis: Results From Discovery and Validation Cohorts
Rebeca Mayo et al.
HEPATOLOGY COMMUNICATIONS (2018)
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
Dharmesh H. Kaswala et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Non-invasive diagnosis of liver fibrosis and cirrhosis
Yoav Lurie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia
Janet D. Sparks et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Human Δ1-pyrroline-5-carboxylate synthase:: function and regulation
C. -A. A. Hu et al.
AMINO ACIDS (2008)
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
Olaf Beckonert et al.
NATURE PROTOCOLS (2007)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell
HM Kagan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)